Company CorMedix Inc.

Equities

CRMD

US21900C3088

Pharmaceuticals

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
4.24 USD +1.92% Intraday chart for CorMedix Inc. +8.72% +12.77%

Business Summary

CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.

Number of employees: 83

Managers

Managers TitleAgeSince
Chief Executive Officer 48 22-03-17
Director of Finance/CFO 47 20-05-10
Chief Tech/Sci/R&D Officer - 21-12-31
General Counsel - Dec. 11
Corporate Officer/Principal 43 19-12-31
Corporate Officer/Principal - 22-05-11
Corporate Officer/Principal - 22-05-11
Corporate Officer/Principal 45 18-02-28

Members of the board

Members of the board TitleAgeSince
Chairman 79 16-04-26
Director of Finance/CFO 68 11-08-14
Director/Board Member 70 19-02-28
Director/Board Member 65 15-08-05
Chief Executive Officer 48 22-03-17
Director/Board Member 59 20-11-01
Director/Board Member 56 23-04-12

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 54,981,102 54,415,049 ( 98.97 %) 0 98.97 %
Stock B 0 181,622 0 0

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
6.148 %
3,369,714 6.148 % 12 M $
2,946,552 5.376 % 10 M $
Vanguard Fiduciary Trust Co.
5.155 %
2,825,335 5.155 % 10 M $
Elliott Investment Management LP
2.829 %
1,550,523 2.829 % 5 M $
Geode Capital Management LLC
2.114 %
1,158,808 2.114 % 4 M $
1,073,134 1.958 % 4 M $
Marshall Wace LLP
0.8447 %
463,006 0.8447 % 2 M $
Northern Trust Investments, Inc.(Investment Management)
0.7504 %
411,307 0.7504 % 1 M $
352,839 0.6437 % 1 M $
Millennium Management LLC
0.5259 %
288,254 0.5259 % 1 M $

Company contact information

CorMedix, Inc.

300 Connell Drive Suite 4200

07922, Berkeley Heights

+908 517 9500

http://www.cormedix.com
address CorMedix Inc.(CRMD)